Skip to content

PURE Bioscience, Inc.

PURE

CIK 0001006028

← back to feed
Revenue (TTM)
$2.15M
+12.2% YoY Q3 Jun 2026
Net Income (TTM)
−$2.45M
+28.4% YoY Q3 Jun 2026
EPS Diluted (TTM)
−$0.03
+33.3% YoY Q3 Jun 2026
Gross Margin
57.7%
Q3 Jun 2026
Operating Margin
-100.7%
Q3 Jun 2026
Net Margin
-114.1%
Q3 Jun 2026
Free Cash Flow (TTM)
−$2.37M
Q3 Jun 2026
Cash
$983K
Q3 Jun 2026
Total Debt
$0
Q3 Jun 2026
Shares Outstanding
130.02M sh
Q3 Jun 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings